Transaction · 0001127602-25-007550

Mock James M

Mock James M, CFO, reported a transaction classified as exercise at Moderna, Inc. involving 329.000000 shares for an estimated $0.00. Reported holdings after the transaction were 2630.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCFO
MRNAModerna, Inc.
Filing timeMar 03
Trade dateFeb 28, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
Returns since

MRNA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MRNA since 2025-03-03Filed 550 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001127602-25-007550
Restricted Stock Units
Transaction date
Feb 28, 2025
Filed Mar 03, 2025, 09:49 PM · 3d delay
Shares
329 sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
2.63k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Restricted stock units convert into common stock on a one-for-one basis.

  2. F2

    Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.

  3. F3

    25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

  4. F4

    25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

  5. F5

    25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Original filing · 0001127602-25-007550
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MRNA